How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

Abstract: This paper studies the control-oriented recursive identification of finite impulse response systems with binary-valued observations. Inspired by the Maximum Likelihood method, a novel ...

Abstract: This paper proposes a new recursive implementation of the Gaussian filter. Previous recursive implementations of the Gaussian filter suffer from one or several drawbacks. Some methods ...

Ben Taylor, CFO of Recursion, here with us. Thanks so much for joining us. Sure. Great. And first of all, thanks for having us here, Tommie. This is always a terrific conference and great to be here.

To use this trace, just keep clicking on the ``Make one step'' button. You can use the ``Finish this call'' button to skip to the step after finishing the current level. The call stack in the display ...

As AI transforms education, we must redefine intelligence beyond biological limits and embrace cognitive functions across ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.06, moving -5.12% from the previous trading session. This change lagged the S&P 500's daily loss of 1.62%. Meanwhile, the Dow ...

In Barrie's Peter Pan, Wendy sewed Peter's mischievous shadow back on his feet. Wendy saw what was incomplete and chose to ...

Buy: Anthropic exposure via its likely IPO/secondary path (e.g., IPO allocation or liquid proxy like AI-safety/compute beneficiaries). Rationale: Anthropic is pushing “slow/pause” policy while still ...